Chinese robotics company Unitree is once again capturing the attention of the global community. This time, engineers have unveiled a prototype of a humanoid robot named "Superman," whose specifications challenge established notions of what anthropomorphic machines can achieve. These are truly impressive figures: a running speed of 12.66 meters per second and a standing vertical jump of two meters. This is not merely an engineering curiosity, but a direct challenge to biological records set in track and field.
Remarkably, the team took just over three months to create this "athlete." However, it is worth emphasizing that "Superman" is still a prototype that is being actively refined. The announcement was deliberately timed ahead of the World Robotics Conference in Beijing, which kicks off on August 19, 2026. The timing is impeccable: the show must go on, and it will draw maximum attention.
Yet, the main intrigue for investors and analysts lies not only in the robot's physical capabilities, but also in the financial aspects of Unitree's operations. Already on August 19, 2026, the company's shares will begin trading on the STAR Market of the Shanghai Stock Exchange. The numbers accompanying this IPO are staggering. The initial public offering was oversubscribed by retail investors more than 8,000 times, indicating enormous demand. The chance for an ordinary retail participant to secure shares was only about 0.018%.
The offering price is set at 150.8 yuan per share, implying a company valuation of approximately 61 billion yuan (about $9 billion). Through the process, Unitree will raise around 6.1 billion yuan (approximately $905 million) before fees. The investor list includes giants such as Tencent, Alibaba, and DeepSeek. Notably, on offshore markets, derivatives were already signaling a strong debut, and the STAR50 index has risen about 15% from its three-month low in early August 2026, creating a favorable backdrop for the stock market entry.
As of July 2026, Unitree has produced a total of about 18,000 bipedal humanoid robots across various models. This is a serious manufacturing base that bolsters the company's ambitious claims. In August, competitor AgiBot claimed leadership in the global humanoid market, leading to disputes over counting methodologies between the two leading industry players.
My take: The success of "Superman" and the overwhelming interest in the IPO are two interconnected signals. The market is voting not just for technology, but for the company's ability to turn innovation into a mass-market product. However, a $9 billion valuation amid such record oversubscription is a double-edged sword. High investor expectations create immense pressure on management. Whether Unitree can sustain its growth pace and justify its market capitalization is the key question for the second half of 2026. For now, we are witnessing a perfect storm: cutting-edge developments, savvy marketing, and a market hungry for new stories.